{"disease":{"id":"chiauranib","name":"chiauranib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04921527","title":"Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":454,"lead_sponsor_name":"Chipscreen Biosciences, Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}